Viewing Study NCT02664103


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-29 @ 12:04 PM
Study NCT ID: NCT02664103
Status: COMPLETED
Last Update Posted: 2018-02-01
First Post: 2016-01-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module